|
1.
|
Beringue V, Couvreur P and Dormont D:
Involvement of macrophages in the pathogenesis of transmissible
spongiform encephalopathies. Dev Immunol. 9:19–27. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Ermolayev V, Cathomen T, Merk J, et al:
Impaired axonal transport in motor neurons correlates with clinical
prion disease. PLoS Pathog. 5:e10005582009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Ogayar A and Sanchez-Perez M: Prions: an
evolutionary perspective. Int Microbiol. 1:183–190. 1998.PubMed/NCBI
|
|
4.
|
Bate C and Williams A: Monoacylated
cellular prion protein modifies cell membranes, inhibits cell
signaling, and reduces prion formation. J Biol Chem. 286:8752–8758.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Hur K, Kim JI, Choi SI, Choi EK, Carp RI
and Kim YS: The pathogenic mechanisms of prion diseases. Mech
Ageing Dev. 123:1637–1647. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Florio T, Paludi D, Villa V, et al:
Contribution of two conserved glycine residues to fibrillogenesis
of the 106-126 prion protein fragment. Evidence that a soluble
variant of the 106-126 peptide is neurotoxic. J Neurochem.
85:62–72. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Anantharam V, Kanthasamy A, Choi CJ, et
al: Opposing roles of prion protein in oxidative stress- and ER
stress-induced apoptotic signaling. Free Radic Biol Med.
45:1530–1541. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Jeong JK, Moon MH, Lee YJ, Seol JW and
Park SY: Autophagy induced by the class III histone deacetylase
Sirt1 prevents prion peptide neurotoxicity. Neurobiol Aging. May
8–2012.(Epub ahead of print).
|
|
9.
|
Nicholls DG and Budd SL: Mitochondria and
neuronal survival. Physiol Rev. 80:315–360. 2000.PubMed/NCBI
|
|
10.
|
Murphy MP and Smith RA: Targeting
antioxidants to mitochondria by conjugation to lipophilic cations.
Annu Rev Pharmacol Toxicol. 47:629–656. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Choi SI, Ju WK, Choi EK, et al:
Mitochondrial dysfunction induced by oxidative stress in the brains
of hamsters infected with the 263 K scrapie agent. Acta
Neuropathol. 96:279–286. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
O’Donovan CN, Tobin D and Cotter TG: Prion
protein fragment PrP-(106-126) induces apoptosis via mitochondrial
disruption in human neuronal SH-SY5Y cells. J Biol Chem.
276:43516–43523. 2001.PubMed/NCBI
|
|
13.
|
Kitazawa M, Wagner JR, Kirby ML,
Anantharam V and Kanthasamy AG: Oxidative stress and
mitochondrial-mediated apoptosis in dopaminergic cells exposed to
methylcyclopentadienyl manganese tricarbonyl. J Pharmacol Exp Ther.
302:26–35. 2002. View Article : Google Scholar
|
|
14.
|
Blokhina O, Virolainen E and Fagerstedt
KV: Antioxidants, oxidative damage and oxygen deprivation stress: a
review. Ann Bot. 91:179–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Park KW and Jin BK: Thrombin-induced
oxidative stress contributes to the death of hippocampal neurons:
role of neuronal NADPH oxidase. J Neurosci Res. 86:1053–1063. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Wang J, Yu Y, Hashimoto F, Sakata Y, Fujii
M and Hou DX: Baicalein induces apoptosis through ROS-mediated
mitochondrial dysfunction pathway in HL-60 cells. Int J Mol Med.
14:627–632. 2004.PubMed/NCBI
|
|
17.
|
Pietri M, Caprini A, Mouillet-Richard S,
et al: Overstimulation of PrPC signaling pathways by prion peptide
106-126 causes oxidative injury of bioaminergic neuronal cells. J
Biol Chem. 281:28470–28479. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Tuccari G and Barresi G: Lactoferrin in
human tumours: immunohistochemical investigations during more than
25 years. Biometals. 24:775–784. 2011.PubMed/NCBI
|
|
19.
|
Brock JH: The physiology of lactoferrin.
Biochem Cell Biol. 80:1–6. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Burrow H, Kanwar RK and Kanwar JR:
Antioxidant enzyme activities of iron-saturated bovine lactoferrin
(Fe-bLf) in human gut epithelial cells under oxidative stress. Med
Chem. 7:224–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Baveye S, Elass E, Mazurier J and Legrand
D: Lactoferrin inhibits the binding of lipopolysaccharides to
L-selectin and subsequent production of reactive oxygen species by
neutrophils. FEBS Lett. 469:5–8. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Iwamaru Y, Shimizu Y, Imamura M, et al:
Lactoferrin induces cell surface retention of prion protein and
inhibits prion accumulation. J Neurochem. 107:636–646. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Jeong JK, Seol JW, Moon MH, et al:
Cellular cholesterol enrichment prevents prion peptide-induced
neuron cell damages. Biochem Biophys Res Commun. 401:516–520. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Kroemer G, Galluzzi L and Brenner C:
Mitochondrial membrane permeabilization in cell death. Physiol Rev.
87:99–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Harris DA: Cellular biology of prion
diseases. Clin Microbiol Rev. 12:429–444. 1999.PubMed/NCBI
|
|
26.
|
Sakudo A and Ikuta K: Prion protein
functions and dysfunction in prion diseases. Curr Med Chem.
16:380–389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Hedlin P, Taschuk R, Potter A, Griebel P
and Napper S: Detection and control of prion diseases in food
animals. ISRN Veterinary Sci. 2012:242012. View Article : Google Scholar
|
|
28.
|
Brown DR and Besinger A: Prion protein
expression and super-oxide dismutase activity. Biochem J.
334:423–429. 1998.
|
|
29.
|
Tsirigotis M, Baldwin RM, Tang MY, Lorimer
IAJ and Gray DA: Activation of p38MAPK contributes to expanded
polyglutamine-induced cytotoxicity. PLoS One. 3:e21302008.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Mai S, Klinkenberg M, Auburger G,
Bereiter-Hahn J and Jendrach M: Decreased expression of Drp1 and
Fis1 mediates mitochondrial elongation in senescent cells and
enhances resistance to oxidative stress through PINK1. J Cell Sci.
123:917–926. 2010. View Article : Google Scholar
|
